CN Patent

CN110483482A — 吲哚啉-1-甲酰胺类化合物、其制备方法及其在医药学上的应用

Assigned to Beijing Nuocheng Jianhua Pharmaceutical Technology Co Ltd · Expires 2019-11-22 · 6y expired

What this patent protects

Patent listed against lenvatinib-mesylate.

Drugs covered by this patent

lenvatinib-mesylate (LENVATINIB MESYLATE)

Patent Metadata

Patent number: CN110483482A
Jurisdiction: CN
Classification: —
Expires: 2019-11-22
Drug substance claim: No
Drug product claim: No
Assignee: Beijing Nuocheng Jianhua Pharmaceutical Technology Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.